Altamir Ord Stocks

23.8Last Updated 13.04.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

€ 1.02B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
23.8
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Altamir SCA formerly known as Altamir Amboise, is a private equity firm specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments. The firm typically invests in the following sectors: healthcare, TMT, digital companies, services, retail and distribution. It also invests in retail and consumer, business and financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. It invests and disinvests with the private equity funds of Apax Partners France and Amboise Investissement under the same conditions and also invests directly in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm seeks to exit its investments within five years. It makes balance sheet investments. Altamir SCA was founded in 1995 and is based in Paris, France.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of LTA.PA is 25 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks